Ines Munuera

Ines Munuera

Auto-generated profile, based on publicly available information

Ines Munuera

Department of Ophthalmology, Miguel Servet University Hospital

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 April 2025 in Drug Delivery
Verified
Journal Article
Open access
MGMiriam Ana González-Cela-Casamayor
Miriam Ana González-Cela-Casamayor
MSMARIA JESUS RODRIGO SANJUAN
MARIA JESUS RODRIGO SANJUAN
MBMarco Brugnera
Marco Brugnera
IMInés Munuera
Inés Munuera
TMTersa Martínez-Rincón
Tersa Martínez-Rincón
RHRocio Herrero-Vanrell
Rocio Herrero-Vanrell
Glaucoma is a multifactorial neurodegenerative disease that affects the retina and optic nerve. The aim of this work was to reach different therapeutics targets by co-encapsulating three neuroprotective substances with hypotensive (latanoprost), antioxidant (melatonin) and anti-inflammatory (ketorolac) activity in biodegradable poly (lactic-co-glycolic acid) (PLGA) microspheres (MSs) capable of releasing the drugs for months after intravitreal injection, avoiding the need for repeated administrations. Multi-loaded PLGA MSs were prepared using the oil-in-water emulsion solvent extraction-evaporation technique and physicochemically characterized. PLGA 85:15 was the polymer ratio selected for the selected formulation. Tri-loaded MSs including vitamin E as additive showed good tolerance in retinal pigment epithelium cells after 24 h exposure (>90% cell viability). The final formulation (KMLVE) resulted in 33.58 ± 5.44 µm particle size and drug content (µg/mg MSs) of 39.70 ± 5.89, 67.28 ± 4.17 and 7.51 ± 0.58 for melatonin, ketorolac and latanoprost respectively. KMLVE were able to release in a sustained manner the three drugs over 70 days. KMLVE were injected at 2 and 12 weeks in Long-Evans rats (n = 20) after the induction of chronic glaucoma. Ophthalmological tests were performed and compared to not treated glaucomatous (n = 45) and healthy (n = 17) animals. Treated glaucomatous rats reached the lowest intraocular pressure, enhanced functionality of bipolar and retinal ganglion cells and showed greater neuroretinal thickness by optical coherence tomography (p < 0.05) compared to not treated glaucomatous rats at 24 weeks follow-up. According to the results, the tri-loaded microspheres can be considered as promising controlled-release system for the treatment of glaucoma.

Verified
Journal Article
Open access
PDF file
IMInes Munuera
Ines Munuera
AAAlba Aragon-Navas
Alba Aragon-Navas
PVPilar Villacampa
Pilar Villacampa
MGMiriam A. Gonzalez-Cela
Miriam A. Gonzalez-Cela
MSManuel Subías
Manuel Subías
MSMARIA JESUS RODRIGO SANJUAN
MARIA JESUS RODRIGO SANJUAN
To evaluate a new animal model of chronic glaucoma induced using a single injection of fibronectin-loaded biodegradable PLGA microspheres (Ms) to test prolonged therapies. 30 rats received a single injection of fibronectin-PLGA-Ms suspension (MsF) in the right eye, 10 received non-loaded PLGA-Ms suspension (Control), and 17 were non-injected (Healthy). Follow-up was performed (24 weeks), evaluating intraocular pressure (IOP), optical coherence tomography (OCT), histology and electroretinography. The right eyes underwent a progressive increase in IOP, but only induced cohorts reached hypertensive values. The three cohorts presented a progressive decrease in ganglion cell layer (GCL) thickness, corroborating physiological age-related loss of ganglion cells. Injected cohorts (MsF > Control) presented greater final GCL thickness. Histological exams explain this paradox: the MsF cohort showed lower ganglion cell counts but higher astrogliosis and immune response. A sequential trend of functional damage was recorded using scotopic electroretinography (MsF > Control > Healthy). It seems to be a function–structure correlation: in significant astrogliosis, early functional damage can be detected by electroretinography, and structural damage can be detected by histological exams but not by OCT. Males presented higher IOP and retinal and GCL thicknesses and lower electroretinography. A minimally invasive chronic glaucoma model was induced by a single injection of biodegradable Ms.

10 January 2024 in Archivos de la Sociedad Española de Oftalmología (English Edition)
Verified
Journal Article
Closed access
IMI. Munuera
I. Munuera
ECE. Gándara-Rodriguez de Campoamor
E. Gándara-Rodriguez de Campoamor
JMJ. Moreno-Montañes
J. Moreno-Montañes

16 April 2024 in Anales del Sistema Sanitario de Navarra
Verified
Journal Article
Open access
IMInes Munuera
Ines Munuera
JSJORGE SANCHEZ-MONROY
JORGE SANCHEZ-MONROY
MPMartin Puzo
Martin Puzo
AMAntonio Mateo
Antonio Mateo
SMSilvia Méndez-Martínez
Silvia Méndez-Martínez
Primary stromal cysts of the iris are rare, often asymptomatic, and incidentally found entities. Treatment is usually indicated in cases of enlargement or complications. However, imaging tests are required to determine their cystic nature and make an accurate differential diagnosis with malignant tumors, as well as for long-term follow-up. Ultrasound biomicroscopy is the technique of choice, although in most centers anterior segment optical coherence tomography is a more accessible and available imaging modality. We present a case of primary stromal cyst of the iris with an atypical presentation to illustrate the diagnosis and initial follow-up using anterior segment optical coherence tomography and photographs, and the management of complications. Anterior segment optical coherence tomography may be useful in the initial study and follow-up of anterior non-pigmented lesions where the cyst can be fully seen.